JCVI-syn3A Minimal Cell
Insulin Release
HIV Vaccine
Escherichia coli Bacterium
Cellulose Synthase
Myoglobin in a Whale Muscle Cell
Collagen and Extracellular Matrix
CytoSkeleton
Transfer RNA and Gag Protein
RecA and DNA
Casein Micelle and Fat Globule in Milk
Model of a Mycoplasma Cell
Phage-based COVID-19 Vaccine
Coronavirus
Immunological Synapse
Coronavirus Life Cycle
Myelin
Respiratory Droplet
SARS-CoV-2 and Neutralizing Antibodies
SARS-CoV-2 Fusion
SARS-CoV-2 mRNA Vaccine
Red Blood Cell Cytoskeleton
Measles Virus Proteins
Lipid Droplets
Poliovirus Neutralization
Influenza Vaccine
Excitatory and Inhibitory Synapses
Abiogenesis
Last Universal Common Ancestor
Zika Virus
Insulin Action
Ebola Virus
Autophagy
Mycoplasma mycoides
Chloroplast
Vascular Endothelial Growth Factor (VegF) Signaling
Biosites: Basement Membrane
Biosites: Red Blood Cell
Biosites: Blood Plasma
Biosites: Cytoplasm
Biosites: Muscle
Biosites: Nucleus
Blood
HIV in Blood Plasma
Escherichia coli

Molecular Landscapes by David S. Goodsell

HIV Vaccine, 2022

Acknowledgement: David S. Goodsell, RCSB Protein Data Bank and Scripps Research. doi: 10.2210/rcsb_pdb/goodsell-gallery-043

This painting shows a new approach to designing vaccines, termed "germline-targeting." The vaccine challenges the immune system with several levels of glycosylation on the vaccine molecule: specific glycans that obscure an epitope are removed from the immunogen, which primes the immune system. In subsequent vaccinations, the glycans are restored to simulate a mature/native protein. Here, a solubilized version of HIV envelope glycoprotein (magenta) is used for the vaccine, and two levels of glycosylation are shown: one fully-glycosylated and one with glycans removed at the receptor-binding site. The glycans that are removed are shown in slightly darker magenta. The vaccine glycoproteins are binding to B-cell receptors (Y-shaped molecules in yellow-green) on the surface of a B-cell (membrane in green, cytoplasm in blue) and activating many signaling proteins inside the cell (shown in blue-green on the inner side of the membrane). Blood plasma is at top, with Y-shaped antibodies in yellow.

Painting created in collaboration with T. G. Caniels in the laboratory of Rogier Sanders at University of Amsterdam and Amsterdam UMC.